Page last updated: 2024-10-21

1-anilino-8-naphthalenesulfonate and Myocardial Ischemia

1-anilino-8-naphthalenesulfonate has been researched along with Myocardial Ischemia in 10 studies

1-anilino-8-naphthalenesulfonate: RN given refers to parent cpd
8-anilinonaphthalene-1-sulfonic acid : A naphthalenesulfonic acid that is naphthalene-1-sulfonic acid substituted by a phenylamino group at position 8.

Myocardial Ischemia: A disorder of cardiac function caused by insufficient blood flow to the muscle tissue of the heart. The decreased blood flow may be due to narrowing of the coronary arteries (CORONARY ARTERY DISEASE), to obstruction by a thrombus (CORONARY THROMBOSIS), or less commonly, to diffuse narrowing of arterioles and other small vessels within the heart. Severe interruption of the blood supply to the myocardial tissue may result in necrosis of cardiac muscle (MYOCARDIAL INFARCTION).

Research Excerpts

ExcerptRelevanceReference
"For the case-control studies, 2110 ischemic heart disease patients vs."1.35Hepatic lipase, genetically elevated high-density lipoprotein, and risk of ischemic cardiovascular disease. ( Andersen, RV; Jensen, GB; Johannsen, TH; Kamstrup, PR; Nordestgaard, BG; Sillesen, H; Tybjaerg-Hansen, A, 2009)

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19901 (10.00)18.7374
1990's1 (10.00)18.2507
2000's4 (40.00)29.6817
2010's4 (40.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Byrne, CD1
Targher, G1
Ikeda, Y1
Hirano, K1
Fukushima, N1
Sawa, Y1
Zhang, H1
Sun, T1
Jiang, X1
Yu, H1
Wang, M1
Wei, T1
Cui, H1
Zhuang, W1
Liu, Z1
Zhang, Z1
Dong, H1
Xu, L1
Jiang, CQ1
Lam, TH1
Zhang, WS1
Zhu, F1
Jin, YL1
Thomas, GN1
Cheng, KK1
Schooling, CM1
Johannsen, TH1
Kamstrup, PR1
Andersen, RV2
Jensen, GB1
Sillesen, H1
Tybjaerg-Hansen, A2
Nordestgaard, BG2
Humphries, SE1
Berglund, L1
Isasi, CR1
Otvos, JD1
Kaluski, D1
Deckelbaum, RJ1
Shea, S1
Talmud, PJ1
Wittrup, HH1
Steffensen, R1
Schnohr, P1
NESTEL, PJ1
Karackattu, SL1
Trigatti, B1
Krieger, M1
Katzel, LI1
Coon, PJ1
Dengel, J1
Goldberg, AP1

Trials

1 trial available for 1-anilino-8-naphthalenesulfonate and Myocardial Ischemia

ArticleYear
Effects of an American Heart Association step I diet and weight loss on lipoprotein lipid levels in obese men with silent myocardial ischemia and reduced high-density lipoprotein cholesterol.
    Metabolism: clinical and experimental, 1995, Volume: 44, Issue:3

    Topics: Aged; Cardiology; Cholesterol, HDL; Diet; Heparin; Humans; Lipase; Lipoprotein Lipase; Lipoproteins;

1995

Other Studies

9 other studies available for 1-anilino-8-naphthalenesulfonate and Myocardial Ischemia

ArticleYear
Liver fat content, non-alcoholic fatty liver disease, and risk of ischaemic heart disease.
    European heart journal, 2018, 09-21, Volume: 39, Issue:36

    Topics: Europe; Genotype; Humans; Lipase; Membrane Proteins; Myocardial Ischemia; Non-alcoholic Fatty Liver

2018
A novel type of human spontaneous coronary atherosclerosis with triglyceride deposition.
    European heart journal, 2014, Volume: 35, Issue:13

    Topics: Adult; Coronary Artery Disease; Foam Cells; Humans; Lipase; Male; Myocardial Ischemia; Triglycerides

2014
PEDF and PEDF-derived peptide 44mer stimulate cardiac triglyceride degradation via ATGL.
    Journal of translational medicine, 2015, Feb-21, Volume: 13

    Topics: Acyltransferases; Amino Acid Sequence; Animals; Cell Hypoxia; Eye Proteins; Lipase; Lipid Droplets;

2015
Mendelian randomization estimates of alanine aminotransferase with cardiovascular disease: Guangzhou Biobank Cohort study.
    Human molecular genetics, 2017, 01-15, Volume: 26, Issue:2

    Topics: Alanine Transaminase; Biological Specimen Banks; Cardiovascular Diseases; Cohort Studies; Female; Ge

2017
Hepatic lipase, genetically elevated high-density lipoprotein, and risk of ischemic cardiovascular disease.
    The Journal of clinical endocrinology and metabolism, 2009, Volume: 94, Issue:4

    Topics: Adult; Amino Acid Substitution; Cardiovascular Diseases; Cerebral Hemorrhage; Cholesterol, HDL; Denm

2009
Loci for CETP, LPL, LIPC, and APOC3 affect plasma lipoprotein size and sub-population distribution in Hispanic and non-Hispanic white subjects: the Columbia University BioMarkers Study.
    Nutrition, metabolism, and cardiovascular diseases : NMCD, 2002, Volume: 12, Issue:4

    Topics: Adult; Apolipoprotein C-III; Apolipoproteins C; Biomarkers; Carrier Proteins; Cholesterol; Cholester

2002
Hepatic lipase mutations,elevated high-density lipoprotein cholesterol, and increased risk of ischemic heart disease: the Copenhagen City Heart Study.
    Journal of the American College of Cardiology, 2003, Jun-04, Volume: 41, Issue:11

    Topics: Adult; Aged; Aged, 80 and over; Apolipoprotein A-I; Apolipoproteins E; Case-Control Studies; Cholest

2003
Observations on heparin-induced clearing activity in ischaemic heart disease and the effect of prolonged heparin therapy.
    Australasian annals of medicine, 1961, Volume: 10

    Topics: Coronary Artery Disease; Coronary Disease; Heparin; Humans; Lipase; Lipid Metabolism; Lipids; Lipopr

1961
Hepatic lipase deficiency delays atherosclerosis, myocardial infarction, and cardiac dysfunction and extends lifespan in SR-BI/apolipoprotein E double knockout mice.
    Arteriosclerosis, thrombosis, and vascular biology, 2006, Volume: 26, Issue:3

    Topics: Age of Onset; Animals; Aorta; Apolipoproteins E; Cardiomegaly; Coronary Artery Disease; Coronary Ves

2006